Accendra Health, Inc. Unrecognized Tax Benefits that Would Impact Effective Tax Rate
Accendra Health, Inc. (ACH) had Unrecognized Tax Benefits that Would Impact Effective Tax Rate of $49.00 million as of 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate · last filed 2026-02-20
- 2025-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $49.00M.
- 2024-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $36.00M; Unrecognized Tax Benefits that Would Impact Effective Tax Rate as first filed $35.00M.
- 2024-09-30: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $35.50M.
- 2023-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $20.00M.
| Period end | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate as first filed |
|---|---|---|
| 2025-12-31 | $49.00M 10-K · filed 2026-02-20 | |
| 2024-12-31 | $36.00M 10-K · filed 2026-02-20 | $35.00M 10-K · filed 2025-02-28 |
| 2024-09-30 | $35.50M 10-Q · filed 2024-11-04 | |
| 2023-12-31 | $20.00M 10-K · filed 2025-02-28 | |
| 2022-12-31 | $19.80M 10-K · filed 2024-02-20 | |
| 2021-12-31 | $18.70M 10-K · filed 2023-02-28 | |
| 2020-12-31 | $18.00M 10-K · filed 2022-02-23 | |
| 2019-12-31 | $8.40M 10-K · filed 2021-02-24 | |
| 2018-12-31 | $7.70M 10-K · filed 2020-03-04 | |
| 2017-12-31 | $6.40M 10-K · filed 2019-03-06 | |
| 2016-12-31 | $5.50M 10-K · filed 2018-02-23 | $4.80M 10-K · filed 2017-02-17 |
| 2015-12-31 | $3.00M 10-K · filed 2017-02-17 | |
| 2014-12-31 | $2.00M 10-K · filed 2016-02-25 | |
| 2013-12-31 | $1.00M 10-K · filed 2015-02-23 | |
| 2012-12-31 | $1.70M 10-K · filed 2014-02-25 | |
| 2011-12-31 | $1.90M 10-K · filed 2013-02-22 | |
| 2010-12-31 | $2.40M 10-K · filed 2012-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HENRY SCHEIN INC (HSIC) | United States | $9.536B | 23.59 |